000 01453 a2200409 4500
005 20250516061439.0
264 0 _c20120321
008 201203s 0 0 eng d
022 _a1873-2518
024 7 _a10.1016/j.vaccine.2011.10.012
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGrimprel, E
245 0 0 _aImmunogenicity and safety of a 13-valent pneumococcal conjugate vaccine (PCV13) when given as a toddler dose to children immunized with PCV7 as infants.
_h[electronic resource]
260 _bVaccine
_cDec 2011
300 _a9675-83 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAntibodies, Bacterial
_xblood
650 0 4 _aFemale
650 0 4 _aFrance
650 0 4 _aHeptavalent Pneumococcal Conjugate Vaccine
650 0 4 _aHumans
650 0 4 _aImmunization, Secondary
_xmethods
650 0 4 _aImmunoglobulin G
_xblood
650 0 4 _aInfant
650 0 4 _aMale
650 0 4 _aPneumococcal Vaccines
_xadministration & dosage
650 0 4 _aVaccination
_xmethods
700 1 _aLaudat, F
700 1 _aPatterson, S
700 1 _aBaker, S A
700 1 _aSidhu, M S
700 1 _aGruber, W C
700 1 _aEmini, E A
700 1 _aScott, D A
773 0 _tVaccine
_gvol. 29
_gno. 52
_gp. 9675-83
856 4 0 _uhttps://doi.org/10.1016/j.vaccine.2011.10.012
_zAvailable from publisher's website
999 _c21241127
_d21241127